Ito K, Kondo H, Hayasaki M, Noda K
Jpn J Antibiot. 1984 Nov;37(11):2193-202.
Concentrations of sulbactam/cefoperazone (SBT/CPZ) in the pelvic dead space exudate were examined in 5 patients who received radical hysterectomy due to uterocervical cancer. Data analysis was performed by the simulation curves prepared from pharmacokinetics parameters using a three-compartment model. Following 1 hour intravenous drip infusion of 2 g of SBT/CPZ, the mean drug concentration in venous blood was 50.62 micrograms/ml for SBT and 120.16 micrograms/ml for CPZ at 1 hour after start of the infusion. The peak SBT level in the pelvic dead space exudate was 21.24 micrograms/ml at 1.58 hours after start of the infusion. The peak CPZ level was 19.13 micrograms/ml at 3.46 hours after start of the infusion. In the treatment of 4 cases with gynecological infections, the clinical efficacy of SBT/CPZ was assessed as effective in 3 cases and poor in 1 case.
对5例因子宫颈癌接受根治性子宫切除术的患者盆腔死腔渗出液中的舒巴坦/头孢哌酮(SBT/CPZ)浓度进行了检测。使用三室模型根据药代动力学参数制备模拟曲线进行数据分析。静脉滴注2g SBT/CPZ 1小时后,输注开始后1小时静脉血中SBT的平均药物浓度为50.62微克/毫升,CPZ为120.16微克/毫升。盆腔死腔渗出液中SBT的峰值水平在输注开始后1.58小时为21.24微克/毫升。CPZ的峰值水平在输注开始后3.46小时为19.13微克/毫升。在4例妇科感染的治疗中,SBT/CPZ的临床疗效评估为3例有效,1例效果不佳。